Business
Nektar Therapeutics to Webcast Presentation at the Cowen and Company 40th Annual Health Care Conference
SAN FRANCISCO, Feb. 28, 2020 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) senior management is scheduled to present at the upcoming Cowen and Company
About this update from Nektar Therapeutics
[{"type":"text","content":"SAN FRANCISCO, Feb. 28, 2020 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) senior management is scheduled to present at the upcoming Cowen and Company 40th Annual Health Care Conference in Boston on Tuesday, March 3, 2020 at 9:20 a.m. Eastern Time.\nThe presentation will be accessible via a webcast through a link posted on the Investor Events section of the Nektar website: http://ir.nektar.com/events-and-presentations/events. This Webcast will be available for replay until April 3, 2020.\nAbout Nektar Nektar Therapeutics is a biopharmaceutical company with a robust, wholly-owned R&D pipeline of investigational medicines in oncology and immunology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.\nContact: \nFor Investors:Vivian Wu of Nektar Therapeutics628-895-0661\n \n View original content:http://www.prnewswire.com/news-releases/nektar-therapeutics-to-webcast-presentation-at-the-cowen-and-company-40th-annual-health-care-conference-301013691.html\nSOURCE Nektar Therapeutics","length":2799,"tagName":"div"}]